IL150479A0 - Treatment of psoriasis - Google Patents

Treatment of psoriasis

Info

Publication number: IL150479A0
Authority: IL; Israel
Prior art keywords: psoriasis; treatment
Prior art date: 2000-03-07

Application number

IL15047901A

Other languages

English (en)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-07

Filing date

2001-02-20

Publication date

2002-12-01

2001-02-20 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2002-12-01 Publication of IL150479A0 publication Critical patent/IL150479A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL15047901A 2000-03-07 2001-02-20 Treatment of psoriasis IL150479A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18750800P	2000-03-07	2000-03-07
PCT/US2001/005260 WO2001066101A2 (en)	2000-03-07	2001-02-20	Treatment of psoriasis

Publications (1)

Publication Number	Publication Date
IL150479A0 true IL150479A0 (en)	2002-12-01

Family

ID=22689272

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15047901A IL150479A0 (en)	2000-03-07	2001-02-20	Treatment of psoriasis

Country Status (19)

Country	Link
US (1)	US6683114B2 (hu)
EP (1)	EP1267859A2 (hu)
JP (1)	JP2003525899A (hu)
KR (1)	KR20020081403A (hu)
CN (1)	CN1407890A (hu)
AU (1)	AU4529101A (hu)
BR (1)	BR0108980A (hu)
CA (1)	CA2400571A1 (hu)
DZ (1)	DZ3282A1 (hu)
EA (1)	EA200200948A1 (hu)
HR (1)	HRP20020729A2 (hu)
HU (1)	HUP0204551A2 (hu)
IL (1)	IL150479A0 (hu)
MX (1)	MXPA02008659A (hu)
NO (1)	NO20024236L (hu)
PL (1)	PL357042A1 (hu)
SK (1)	SK12812002A3 (hu)
WO (1)	WO2001066101A2 (hu)
ZA (1)	ZA200205266B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050013853A1 (en) *	2000-11-29	2005-01-20	Irit Gil-Ad	Anti-proliferative drugs
IL139975A0 (en) *	2000-11-29	2002-02-10	Univ Ramot	Anti proliferative drugs
CN2559015Y (zh) *	2002-04-29	2003-07-02	谢基生	电动式双层近红外滤光型防盗摄影监控装置
US20040229849A1 (en) *	2002-09-24	2004-11-18	Jost-Price Edward Roydon	Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040220153A1 (en) *	2002-09-24	2004-11-04	Jost-Price Edward Roydon	Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004075902A1 (en) *	2003-02-28	2004-09-10	Amedis Pharmaceuticals Ltd.	Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder
EP1708717B1 (en) *	2003-07-28	2011-10-05	Leslie Joe Dunaway	Atomoxetine for treatment of allergic rhinitis and asthma
US20100279990A1 (en) *	2006-06-13	2010-11-04	Ramot At Tel-Aviv University Ltd.	Antiproliferative compounds, compositions and methods of use
US20080081067A1 (en) *	2006-10-03	2008-04-03	Gupta Manishkumar	Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US20100069389A1 (en) *	2008-09-06	2010-03-18	Bionevia Pharmaceuticals, Inc.	Novel forms of reboxetine
PT2838510T (pt) *	2013-11-08	2016-11-23	Lilly Co Eli	Solução de atomoxetina

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU183323B (en) *	1981-02-11	1984-04-28	Richter Gedeon Vegyeszet	Process for producing 17,18-dihydro-apovincaminol-3-comma down comma aaove-4-comma down comma above-5-comma down comma aaove-trimethoxy-benzoate and acid additional salts thereof
CA2134038C (en) *	1994-06-16	1997-06-03	David Taiwai Wong	Potentiation of drug response
US5508276A (en) *	1994-07-18	1996-04-16	Eli Lilly And Company	Duloxetine enteric pellets
US5658590A (en) *	1995-01-11	1997-08-19	Eli Lilly And Company	Treatment of attention-deficit/hyperactivity disorder
US6150396A (en) *	1997-03-07	2000-11-21	Eli Lilly And Company	Methods of treating or preventing interstitial cystitis
US5916910A (en) *	1997-06-04	1999-06-29	Medinox, Inc.	Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
ZA985765B (en) *	1997-07-02	1999-08-04	Merck & Co Inc	Polymorphic form of a tachykinin receptor antagonist.
UA56257C2 (uk) *	1997-09-23	2003-05-15	Елі Ліллі Енд Компані	Спосіб лікування неадекватної визивної поведінки
KR20010034758A (ko) *	1998-04-09	2001-04-25	로렌스 티. 마이젠헬더	신경 장애의 신규 치료 방법
US6197828B1 (en) *	1998-12-01	2001-03-06	Sepracor, Inc.	Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en) *	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6403645B2 (en) *	2000-03-16	2002-06-11	President And Fellows Of Harvard College	Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them

2001
- 2001-02-20 DZ DZ013282A patent/DZ3282A1/fr active
- 2001-02-20 CA CA002400571A patent/CA2400571A1/en not_active Abandoned
- 2001-02-20 MX MXPA02008659A patent/MXPA02008659A/es not_active Application Discontinuation
- 2001-02-20 KR KR1020027011664A patent/KR20020081403A/ko not_active Application Discontinuation
- 2001-02-20 WO PCT/US2001/005260 patent/WO2001066101A2/en not_active Application Discontinuation
- 2001-02-20 EA EA200200948A patent/EA200200948A1/ru unknown
- 2001-02-20 JP JP2001564754A patent/JP2003525899A/ja not_active Withdrawn
- 2001-02-20 CN CN01805911A patent/CN1407890A/zh active Pending
- 2001-02-20 EP EP01918185A patent/EP1267859A2/en not_active Withdrawn
- 2001-02-20 PL PL01357042A patent/PL357042A1/xx not_active Application Discontinuation
- 2001-02-20 IL IL15047901A patent/IL150479A0/xx unknown
- 2001-02-20 US US10/203,403 patent/US6683114B2/en not_active Expired - Fee Related
- 2001-02-20 BR BR0108980-3A patent/BR0108980A/pt active Pending
- 2001-02-20 AU AU45291/01A patent/AU4529101A/en not_active Abandoned
- 2001-02-20 SK SK1281-2002A patent/SK12812002A3/sk unknown
- 2001-02-20 HU HU0204551A patent/HUP0204551A2/hu unknown
2002
- 2002-07-01 ZA ZA200205266A patent/ZA200205266B/en unknown
- 2002-09-05 HR HR20020729A patent/HRP20020729A2/xx not_active Application Discontinuation
- 2002-09-05 NO NO20024236A patent/NO20024236L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2003525899A (ja)	2003-09-02
BR0108980A (pt)	2003-06-03
NO20024236D0 (no)	2002-09-05
EP1267859A2 (en)	2003-01-02
US6683114B2 (en)	2004-01-27
CA2400571A1 (en)	2001-09-13
US20030045585A1 (en)	2003-03-06
HUP0204551A2 (hu)	2003-06-28
MXPA02008659A (es)	2003-02-24
HRP20020729A2 (en)	2004-02-29
PL357042A1 (en)	2004-07-12
DZ3282A1 (fr)	2001-09-13
CN1407890A (zh)	2003-04-02
NO20024236L (no)	2002-09-05
WO2001066101A3 (en)	2002-02-07
AU4529101A (en)	2001-09-17
ZA200205266B (en)	2003-10-01
WO2001066101A2 (en)	2001-09-13
EA200200948A1 (ru)	2003-02-27
SK12812002A3 (sk)	2003-08-05
KR20020081403A (ko)	2002-10-26

Publication	Publication Date	Title
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
GB0014969D0 (en)	2000-08-09	Novel method of treatment
GB2393202B (en)	2005-12-21	Methods of well treatment
IL151132A0 (en)	2003-04-10	Pteridine compounds for the treatment of psoriasis
AU5464601A (en)	2001-09-12	Treatment of scale
EP1368024A4 (en)	2009-03-18	TREATMENT OF RESTENOSIS
HRP20020729A2 (en)	2004-02-29	Treatment of psoriasis
AU5000001A (en)	2001-09-03	Treatment of vitiligo
GB0124124D0 (en)	2001-11-28	Methods of treatment
GB2360453B (en)	2004-09-01	Treatment of skin conditions
AU9402401A (en)	2002-04-22	Treatment of cancers
GB0020588D0 (en)	2000-10-11	Treatment of wounds
AU2001261324A1 (en)	2001-11-20	Psoriasis treatment
GB0008921D0 (en)	2000-05-31	Method of treatment
GB0101146D0 (en)	2001-02-28	Treatment of skin conditions
IL161630A0 (en)	2004-09-27	Methods of treating endometreosis
EP1303281A4 (en)	2006-02-15	METHODS OF TREATMENT
GB0127006D0 (en)	2002-01-02	Treatment of moccasion seam
AU6191201A (en)	2001-12-11	Treatment of effluent
GB0014904D0 (en)	2000-08-09	Methods of treatment
GB0013928D0 (en)	2000-08-02	Methods of treatment
GB0008161D0 (en)	2000-05-24	Treatment of cancer
EP1158991A4 (en)	2003-05-14	ASTHMA TREATMENT
TJ99000555A (en)	2000-08-07	Method of treatment of psoriasis
GB0026742D0 (en)	2000-12-20	Novel method of treatment